fig3
![CCEPAS: the creation and validation of a fast and sensitive clinical whole exome analysis pipeline based on gene and variant ranking](https://image.oaes.cc/b65a3519-5c16-4399-8fa3-f36e32caa9e3/2378.fig.3.png)
Figure 3. Pheno2Gene validation summary. (A) The validation consisted of using 10 well known syndromes, that are rare to ultra rare with a variety of clinical features; (B) the validation parameters demonstrated that Pheno2Gene is as accurate as Phenomizer and Ingenuity, but it is more sensitive and specific. MCAD: medium-chain acyl-CoA dehydrogenase